Kelly J. Gordon, Ph.D.
Affiliations: | 2008 | Duke University, Durham, NC |
Area:
Cell Biology, OncologyGoogle:
"Kelly Gordon"Parents
Sign in to add mentor| Gerard C. Blobe | grad student | 2008 | Duke | |
| (Role of the transforming growth factor beta type III receptor in the epithelial to mesenchymal transition during pancreatic carcinogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lourenco AP, Benson KL, Henderson MC, et al. (2017) A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years. Clinical Breast Cancer |
| Henderson MC, Hollingsworth AB, Gordon K, et al. (2016) Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer. Plos One. 11: e0157692 |
| Gordon KJ, Kirkbride KC, How T, et al. (2009) Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2 Carcinogenesis. 30: 238-248 |
| Gordon KJ, Blobe GC. (2008) Role of transforming growth factor-β superfamily signaling pathways in human disease Biochimica Et Biophysica Acta - Molecular Basis of Disease. 1782: 197-228 |
| Gordon KJ, Dong M, Chislock EM, et al. (2008) Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis. 29: 252-62 |
| Dong M, How T, Kirkbride KC, et al. (2007) The type III TGF-beta receptor suppresses breast cancer progression. The Journal of Clinical Investigation. 117: 206-17 |